Status:
COMPLETED
Cone Beam CT Scanning in Lung and Bladder Cancer.
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Lung Neoplasm
Small Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.
Eligibility Criteria
Inclusion
- Patient has biopsy proven limited stage SCLC
- receiving radical concurrent chemoradiotherapy
- no prior chest RT
- no prior surgical resection of lung tumor
- no prior chemotherapy
- patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
- patient has biopsy proven TCC bladder
- receiving radical concurrent chemoradiotherapy or RT alone
- no prior chemotherapy
- patient signs study-specific consent form
Exclusion
- mixed small cell and non small cell histology
- patient not being treated with concurrent chemoradiotherapy
- chemoradiotherapy given sequentially
- previous chest RT
- previous chemotherapy
- prior surgical resection of lung mass
- patient ineligible for pelvic RT
- patient does not sign study consent
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00469066
Start Date
May 1 2007
End Date
April 1 2010
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada